Developing novel therapeutics requires more than operational efficiency; it demands a structured, compliant, and forward-thinking approach to the stringent guidelines set forth by health authorities. Protheragen understands that you need a trusted partner to support your product's access to the market efficiently and as early as possible. Navigating the regulatory landscape requires a nuanced understanding of current legislative frameworks and agency expectations.
We maintain a professional team of regulatory affairs specialists responsible for the observation and analysis of United States and international regulatory evolutions that might potentially impact the development and registration of your products. As your full-service regulatory partner, we provide comprehensive registration services covering the entire lifecycle of a project implementation, alongside regulatory consultation services to minimize risk and maximize strategic benefit.
With extensive experience in managing both innovative and modified new drug projects, Protheragen delivers integrated regulatory affairs support that emphasizes compliance, efficiency, and strategic alignment. Our approach combines deep expertise with proactive regulatory insight to streamline development processes, reduce potential risks, and support successful product advancement without duplicating prior assessments of regulatory trends or frameworks.
We manage various registration types throughout all development stages, providing complete operational and strategic support.
Development of lifecycle-spanning registration strategies informed by comparative analysis of international regulatory differences and comprehensive risk assessments.
Complete registration dossier preparation and formal submission, including eCTD formatting, publishing, validation, and electronic submission.
Dedicated review communication and registration support, as U.S. Agent representation, and provision of essential FDA submission resources.
Comprehensive management of post-approval obligations and annual maintenance activities to sustain product compliance.
Beyond formal submissions, we deliver objective analyses and strategic guidance to proactively navigate complex development hurdles.
Continuous monitoring, tracking, and assessment of regulatory updates, providing timely intelligence, interpretation, and actionable insights to support informed decision-making.
Design and implementation of tailored regulatory strategies aligned with your product profile and target markets, ensuring efficient pathways to approval.
Comprehensive support for specific product registrations, including documentation preparation, submission management, and communication with regulatory authorities.
Professional regulatory training programs combined with flexible, client-specific solutions to address unique project needs and enhance internal capabilities.
Our regulatory affairs team has substantial experience supporting a wide range of product types.
Small Molecule Drugs
Antibodies
Recombinant Proteins
Cancer Vaccines
Peptide-Drug Conjugates (PDC)
Get in touch with our regulatory experts to discuss your project needs and discover how we can support your path to successful product development and market entry. Whether you require strategic guidance, registration support, or tailored regulatory solutions, our team is ready to assist with responsive, knowledgeable service.
1. At what stage of development should we engage your Regulatory Affairs team?
We strongly advocate for engagement at the earliest possible stage of development. Involving our regulatory experts during the initial planning phases allows us to optimize your overarching clinical strategy, ensure early-phase trial designs meet later-stage regulatory requirements, and ultimately prevent costly delays or fundamental protocol revisions down the line.
2. Do you support eCTD submissions for the FDA?
Yes, we provide comprehensive support for the Electronic Common Technical Document (eCTD) format, which is the mandatory standard required by the FDA and other global health authorities for regulatory submissions. Our services include dossier compilation, formatting, document publishing, and final electronic submission. We ensure that all modules are accurately structured, validated, and hyperlinked according to strict agency specifications.
3. Can Protheragen act as our U.S. Agent for FDA interactions?
Absolutely. For sponsors and manufacturers located outside the United States, designating a U.S. Agent is a mandatory regulatory requirement. Protheragen can serve as your official U.S. Agent, acting as the primary point of contact between your organization and the FDA. In this capacity, we facilitate all essential communications, assist in scheduling authority meetings, and provide necessary FDA submission resources to ensure your operations proceed smoothly.
4. How do you handle post-approval regulatory maintenance?
Regulatory compliance extends well beyond the initial market approval. We provide comprehensive post-approval lifecycle management services to ensure your product remains in good standing. This includes the preparation and submission of annual reports, post-marketing safety updates, and manufacturing supplementary applications. Whether you are expanding clinical indications or modifying production processes, our team manages the necessary regulatory filings to maintain compliance.